March 20, 2020
Brazilian pharmaceutical company Hypera Pharma said on Wednesday that it agreed to sell 12 brands marketed outside the country to local drugmaker Eurofarma Laboratórios for $161 million.
The 12 over-the-counter (OTC) and prescription drugs are part of the 18 brands that Hypera agreed to buy earlier this month from Japan's Takeda Pharmaceutical Company for $825 million.
"The purchase price is proportional to the relevance of the assets with respect to the business to be acquired from Takeda," Hyp
Brazilian pharmaceutical company agrees to sell 12 recently acquired OTC and prescription drugs for $161 mln